Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

LEEEUL BIO SCIENCE

Explore full profile

Regenerative aesthetic cosmetics and wound dressings

Seoul, South Korea
Valuation $50–100M Last recorded · 2024
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for LEEEUL BIO SCIENCE and the history behind them.

About LEEEUL BIO SCIENCE

LEEEUL BIO SCIENCE, also known as Eul Biosciences, is a South Korean life science company specializing in medical treatments. The firm develops regenerative aesthetic cosmetics and wound dressings that utilize stem cells and stem cell-derived exosomes. This technology is designed to improve exosome production for their clients.

The company operates in the biotechnology and drug discovery industries. It maintains a privately held ownership status and is backed by venture capital. In a Series A funding round on September 24, 2024, the company raised $11.2 million. Investors in Eul Biosciences include Ace Investment & Finance Co., Industrial Bank of Korea, Mirae Asset Venture Investment, Pathway Partners, and Peakline Partners.

Source: Dealroom company data

At a glance

Status
Operational
Headquarters
Seoul, South Korea
Open positions
None listed
Dealroom signal
0.0/100
Links
Website

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Sep 2024 $13M $51M Mirae Asset Venture Investment · Ulmus Investment · Pathway Partners · Industrial Bank of Korea —
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

LEEEUL BIO SCIENCE website traffic

Latest recorded traffic for LEEEUL BIO SCIENCE is 70 monthly website visits, down 91% over the last three months.

Latest monthly visits70 3-month web change-91%
Monthly website visitsFeb 2025–Apr 2026
Explore monthly traffic historyTrack growth over time and compare with peersBook a demo
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

0 profiles shownExplore the complete relationship graph →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • Mirae Asset Venture Investment
  • Ulmus Investment
  • Pathway Partners
  • Industrial Bank of Korea

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇰🇷 South Korea · Seoul HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about LEEEUL BIO SCIENCE on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See LEEEUL BIO SCIENCE’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.